ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 90 Tablets per bottle, Rx Only, Manufactured for Accord Healthcar…
- Recall date
- September 16, 2025
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0006-2026
- FDA classification
- Class II
- Brand / firm
- ACCORD HEALTHCARE, INC.
- Sold / distributed
- Nationwide in the US
Why it was recalled
Subpotent: During long term stability testing of Levothyroxine Sodium Tablets USP for 88 mcg, the assay content was observed below the approved specification range.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 90 Tablets per bottle, Rx Only, Manufactured for Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-450-15.
Get recall alerts
Free email alert whenever ACCORD HEALTHCARE, INC. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: ACCORD HEALTHCARE, INC.